ArTS Archivio della ricerca di Trieste

MUSTACCHI, GIORGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 22.128
NA - Nord America 4.443
AS - Asia 952
SA - Sud America 49
AF - Africa 21
Continente sconosciuto - Info sul continente non disponibili 20
OC - Oceania 3
Totale 27.616
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 19.822
US - Stati Uniti d'America 4.431
SG - Singapore 439
UA - Ucraina 388
FR - Francia 361
SE - Svezia 319
HK - Hong Kong 193
GB - Regno Unito 183
DE - Germania 174
CN - Cina 168
CH - Svizzera 155
NL - Olanda 143
FI - Finlandia 121
RU - Federazione Russa 92
TR - Turchia 70
IE - Irlanda 65
BG - Bulgaria 62
PL - Polonia 44
BR - Brasile 41
RO - Romania 38
ES - Italia 30
AL - Albania 28
IN - India 25
BE - Belgio 22
EU - Europa 20
CI - Costa d'Avorio 16
IR - Iran 14
DK - Danimarca 12
PT - Portogallo 12
GR - Grecia 11
CA - Canada 9
CZ - Repubblica Ceca 9
MY - Malesia 9
AT - Austria 8
IL - Israele 7
SI - Slovenia 6
SM - San Marino 6
HR - Croazia 4
JP - Giappone 4
LU - Lussemburgo 4
SA - Arabia Saudita 4
CL - Cile 3
IQ - Iraq 3
KR - Corea 3
MD - Moldavia 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
GE - Georgia 2
MT - Malta 2
NZ - Nuova Zelanda 2
VN - Vietnam 2
AM - Armenia 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CF - Repubblica Centrafricana 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EG - Egitto 1
HU - Ungheria 1
JM - Giamaica 1
JO - Giordania 1
LB - Libano 1
MA - Marocco 1
MX - Messico 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
SN - Senegal 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
VA - Santa Sede (Città del Vaticano) 1
Totale 27.616
Salva come PNG Salva come JPEG
Città #
Rome 1.118
Milan 1.068
Woodbridge 538
Ann Arbor 424
Fairfield 379
Jacksonville 340
Houston 330
Chandler 320
Naples 313
Singapore 275
Ashburn 231
Florence 218
Wilmington 218
Turin 193
Hong Kong 191
Bologna 185
Seattle 182
Padova 158
Palermo 157
Trieste 150
Napoli 138
Cambridge 132
Princeton 118
Boardman 113
Torino 109
Bari 108
Genoa 97
Catania 96
Brescia 91
Santa Clara 77
Cagliari 72
Verona 72
Dallas 71
Perugia 63
Columbus 61
Dublin 60
Sofia 59
Izmir 57
Bergamo 56
Pescara 45
Monza 44
Moscow 44
Caserta 43
Beijing 42
Messina 42
Genova 41
Mountain View 41
Udine 41
Como 40
Treviso 37
Venezia 37
Dearborn 36
Reggio Calabria 36
Vicenza 34
Sassari 32
Modena 30
Pisa 30
Ancona 29
Lucca 29
Taranto 29
Latina 28
San Diego 28
Catanzaro 27
Reggio Nell'emilia 26
Venice 26
Parma 25
Prato 25
Livorno 24
Pavia 23
Salerno 23
Bremen 22
Foggia 22
Redwood City 22
Novara 21
Trento 21
Siena 20
Ferrara 19
Abbiategrasso 18
Legnano 18
Mestre 18
Redmond 18
Mumbai 17
Ravenna 17
Abidjan 16
Busto Arsizio 16
Duino-Aurisina 16
Rende 16
Rimini 16
Torre Del Greco 16
Bolzano 15
Reggio Emilia 15
Altamura 14
Civitanova Marche 14
Dalmine 14
Lugano 14
Potenza 14
Quartu Sant'elena 14
San Mateo 14
Scafati 14
Alessandria 13
Totale 10.179
Salva come PNG Salva come JPEG
Nome #
Valutazione quantitativa di Ki-67 nel carcinoma mammario: comparazione tra lettura al microscopio ottico e lettura con analizzatore automatico 21.336
Advances in systemic therapy for metastatic breast cancer: future perspectives 336
Prognostic-predictive factors in breast cancer: comparison of mRNA level (Target Print) and immunohistochemistry expression 195
Acneiform rash due to epidermal growth factor receptor inhibitors: high-level laser therapy as an innovative approach. 188
Biology, prognosis and response to therapy of breast carcinomas according to HER2 score 184
Breast cancer in elderly women: a different reality? Results from the NORA Study 160
Maintenance capecitabine and bevacizumab versus bevacizumab alone after initial first-line bevacizumab and docetaxel for patients with HER2-negative metastatic breast cancer (IMELDA): a randomised, open-label, phase 3 trial 155
Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: evidence from a retrospective study. 153
Adjuvant systemic treatment of early breast cancer: The NORA study. 152
Role of lifestyles in breast cancer risk: a retrospective analysis of Trieste's female population 151
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. 145
Neo-adjuvant exemestane in elderly patients with breast cancer: a phase II, multicentre, open-label, Italian study 145
Gene expression profiling in breast cancer: A clinical perspective 138
A Phase II study of cisplatin and vinorelbine in patients with metastatic breast cancer. 136
Erratum to: Advances in systemic therapy for metastatic breast cancer: future perspectives (Medical Oncology, (2017), 34, 7, (119), 10.1007/s12032-017-0975-5) 134
The burden of renal cell cancer: A retrospective longitudinal study on occurrence, outcomes and cost using an administrative claims database 132
Tamoxifen versus surgery plus Tamoxifen as primary treatment for elderly patients with breast cancer: combined data from the “GRETA” and “CRC” trials 131
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancerdeath: meta-analysis of individual patient data for 10,801 women in 17 randomised trials 130
Adjuvant treatment of early breast cancer: do the St Gallen recommendations influence clinical practice? Results from the NORA study 129
Psychological Response to Cancer: Role of 5-HTTLPR Genetic Polymorphism of Serotonin Transporter 127
Early detection of breast cancer recurrences through periodic follow up - Is it useless? 125
Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. 120
The anthracyclines and the clinical practice: do all breast cancer patients benefit? Results from the NORA study. 119
Identification and Validation of a New Set of Five Genes for Prediction of Risk in Early Breast Cancer 119
Clinical efficacy and endocrine activity of vorozole in postmenopausal breast cancer patients. Results of a multicentric phase II study. 118
Cost-effectiveness and sustainability of breast cancer screening and new anti-cancer drugs 109
Sequential Tamoxifen and Aminoglutethimide Versus Tamoxifen Alone in the Adjuvant Treatment of Postmenopausal Breast cancer Patients: Results of an Italian Cooperative Study 107
Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: experience from the Italian observational NEMESI study. Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: experience from the Italian observational NEMESI study 104
An induction dose of epoietin alpha of 40.000 IU daily for three consecutive days increases and mantains hemoglobin levels in anemic cancer patients undergoing chemotherapy. 103
Molecular targets of cancer chemotherapy 101
La metanalisi di Oxford del 2000: riflessioni e commenti 101
Annual Hazard Rates of Recurrence for early breast cancer. What has changed in the last 10 years? Results from the NORA study. 101
Cancro del fegato: possibilità di diagnosi precoce 101
ITALIAN BREAST CANCER ADJUVANT CHEMO-HORMONE THERAPY COOPERATIVE GROUP TRIALS 99
Changes in adjuvant treatment of early breast cancer in Italy between 2000 and 2008. The NEMESI study versus the NORA study. 99
A multicentre, double blind, randomised trial comparing ondansetron plus dexamethasone in the prophylaxis of cisplatin-induced delayed emesis 97
Chemotherapy vs Tamoxifen vs Chemotherapy + Tamoxifen in Node-positive, Oestrogen-receptor positive Breast Cancer Patients. An update at 7 years of the 1st GROCTA Trial. 97
Gli antidoti in Oncologia medica: efficacia, costo e beneficio 95
Carcinoma dell’ovaio 95
Effectiveness of magnetotheraphy in resolution of some early complications of the mastectomy operation. 94
Modulating effect of Lonidamine on Response to Doxorubicin in Metastatic Breast cancer patients: Results from a Multicenter Prospective Randomized Trial. 94
Il Carcinoma del Fegato: Realtà e Prospettive Epidemiologia 91
Un programme de réhabilitation chez la femme mastectomisée 86
The combination of Metoclopramide, Methylprednisolone and Ondansetron against antiblastic - delayed emesis: a randomised Phase II study. 85
Extragonadal Germ Cell Tumor: a Clinical Stdy. 84
Prevention of chemotherapy-induced early menopause in early breast cancer patients. A phase III multicenter study of GIM Group 84
Chemotherapy vs Tamoxifen vs Chemotherapy + Tamoxifen in Node-positive, Oestrogen-receptor positive Breast Cancer Patients. An update at 8 years of the first GROCTA (Italian Cooperative Group for Adjuvant Chemo-Hormonal Therapy of Breast cancer)Trial. 77
La communication du diagnostic de cancer 75
Corrigendum to "Gene expression profiling in breast cancer: A clinical perspective" [The Breast 22 (2013) 109-120 [doi:10.1016/j.breast.2013.01.016.]] 74
Ovarian function in premenopausal women affected by breast cancer: the measurement of glucuronoconjugate metabolites of 17-beta-estradiol and progesterone throughout one entire menstrual cycle 71
Relapse rate after adjuvant trastuzumab in the northeast of Italy: Preliminary data from a multicenter observational study in a clinical setting. J Clin Oncol 30, 2012 (suppl; abstr 586) 69
Effect of menstrual status on response to adjuvant chemotherapy and /or endocrine therapy. 66
Observer variations in mammary thermography: results of a teaching file test carried out in four different centers 65
Tamoxifen or Surgery plus Tamoxifen as primary treatment for elderly patients with operable breast cancer: the G.R.E.T.A. Trial 61
Tamoxifen alone versus adjuvant tamoxifen for operable breast cancer of the elderly: long term results of the phase III randomized controlled multicenter “GRETA” trial. 59
Factors influencing the switch from tamoxifen to aromatase inhibitors as adjuvant therapy in early breast cancer patients. Results from the NORA Study 58
Switching to an aromatase inhibitor provides mortality benefit in early breast carcinoma: pooled analysis of 2 consecutive trials. 58
Prolonged Tamoxifen Treatment of Early Breast Cancer: The experience of the Italian Cooperative Group for Chemo-Hormonal Therapy of Early Breast Cancer. 56
Role of erythropoietin in the oncology patient: critical review of the literature 51
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies 48
Multiple Bayesian network meta-analyses to establish therapeutic algorithms for metastatic triple negative breast cancer 38
Totale 27.911
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.215
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.215
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020614 0 0 0 0 0 0 0 0 0 192 244 178
2020/20212.813 281 286 258 311 196 227 171 214 226 253 185 205
2021/20221.895 112 142 124 154 121 95 101 110 211 171 169 385
2022/20234.469 323 320 351 347 367 472 293 369 427 284 451 465
2023/20243.525 447 401 315 332 273 185 351 326 76 289 283 247
2024/20252.433 274 286 485 246 235 208 167 153 304 75 0 0
Totale 27.911